Literature DB >> 16799916

Changing patterns of drug utilization in a neonatal intensive care population.

Wei Du1, Indulekha Warrier, Victoria Tutag Lehr, Vali Salari, Enrique Ostrea, Jacob V Aranda.   

Abstract

Newborns in the neonatal intensive care unit (NICU) typically are exposed to a large number of drugs and are especially vulnerable to adverse drug reactions. It is important to review changes in drug use patterns periodically in the NICU to identify newly introduced drugs as well as drugs with increasing use. The objective of this study was to determine the changes in drug utilization patterns over a 7-year period in an NICU population. Drug utilization of 2332 neonates treated at an intramural NICU between January 1, 1997 and December 31, 1998, and 2691 neonates between January 1, 2001 and June 30, 2004 was analyzed using chi-square tests, T tests, and linear regression. There was an increased utilization of antibiotics, central nervous system drugs, endocrine agents, cardiovascular and gastrointestinal drugs, and a decreased utilization of ophthalmic drugs. No changes in nutritional, biological, renal, and pulmonary drugs were observed. Some individual drug changes include an increased use of vancomycin, cefepime, caffeine, and a decreased use of morphine. Significant changes in drug utilization patterns in an NICU were observed during a 7-year period. These data are useful in monitoring drug resistance patterns, adverse drug reactions, and prioritizing areas of relevant therapeutic research and educational programs.

Entities:  

Mesh:

Year:  2006        PMID: 16799916     DOI: 10.1055/s-2006-946719

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  11 in total

1.  Drug utilisation profile in the neonatal unit of a university hospital: a prospective observational study in Brazil.

Authors:  Adriana Cristina de Souza Gonçalves; Adriano Max Moreira Reis; Ana Carolina Marçal Gusmão; Maria Cândida Ferrarez Bouzada
Journal:  Int J Clin Pharm       Date:  2015-04-02

2.  Gastrointestinal colonization with ESBL-producing Klebsiella in preterm babies--is vancomycin to blame?

Authors:  N Ofek-Shlomai; S Benenson; Z Ergaz; O Peleg; R Braunstein; B Bar-Oz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-04       Impact factor: 3.267

Review 3.  Innovative clinical trial design for pediatric therapeutics.

Authors:  Matthew M Laughon; Daniel K Benjamin; Edmund V Capparelli; Gregory L Kearns; Katherine Berezny; Ian M Paul; Kelly Wade; Jeff Barrett; Phillip Brian Smith; Michael Cohen-Wolkowiez
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

4.  Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants.

Authors:  Raul Chavez Valdez; Rajni Ahlawat; Marsha Wills-Karp; Amy Nathan; Tarrah Ezell; Estelle B Gauda
Journal:  J Pediatr       Date:  2010-08-06       Impact factor: 4.406

Review 5.  Variation of the prevalence of pediatric polypharmacy: A scoping review.

Authors:  Courtney Baker; James A Feinstein; Xuan Ma; Shari Bolen; Neal V Dawson; Negar Golchin; Alexis Horace; Lawrence C Kleinman; Sharon B Meropol; Elia M Pestana Knight; Almut G Winterstein; Paul M Bakaki
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-02-06       Impact factor: 2.890

6.  Drug labeling and exposure in neonates.

Authors:  Matthew M Laughon; Debbie Avant; Nidhi Tripathi; Christoph P Hornik; Michael Cohen-Wolkowiez; Reese H Clark; P Brian Smith; William Rodriguez
Journal:  JAMA Pediatr       Date:  2014-02       Impact factor: 16.193

7.  Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis.

Authors:  Antje Neubert; Kristin Lukas; Thomas Leis; Harald Dormann; Kay Brune; Wolfgang Rascher
Journal:  Eur J Clin Pharmacol       Date:  2009-09-16       Impact factor: 2.953

8.  Drug Utilization on Neonatal Wards: A Systematic Review of Observational Studies.

Authors:  Rosliana Rosli; Ahmad Fauzi Dali; Noorizan Abd Aziz; Amir Heberd Abdullah; Long Chiau Ming; Mohamed Mansor Manan
Journal:  Front Pharmacol       Date:  2017-02-08       Impact factor: 5.810

Review 9.  Defining pediatric polypharmacy: A scoping review.

Authors:  Paul M Bakaki; Alexis Horace; Neal Dawson; Almut Winterstein; Jennifer Waldron; Jennifer Staley; Elia M Pestana Knight; Sharon B Meropol; Rujia Liu; Hannah Johnson; Negar Golchin; James A Feinstein; Shari D Bolen; Lawrence C Kleinman
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

10.  Use of off-label and unlicensed medicines in neonatal intensive care.

Authors:  Haline Tereza Matias de Lima Costa; Tatiana Xavier Costa; Rand Randall Martins; Antônio Gouveia Oliveira
Journal:  PLoS One       Date:  2018-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.